血清癌抗原15.3和细针吸取细胞学对乳腺癌诊断的比较  

Comparison Between Serum Cancer Antigen 15.3 Diagnosing Mammary Cancer and Fine Needle Aspination Cytology Diagnosing Mammary Cancer

作　　者：张柏梁[1] 常丽霞[2] 

机构地区：[1]铁岭市卫生学校,辽宁铁岭112000 [2]铁岭市中心医院,辽宁铁岭112000

出　　处：《实用医技杂志》2006年第8期1235-1236,共2页Journal of Practical Medical Techniques

摘　　要：目的:分析血清癌抗原15.3(CA15.3)和细针吸取细胞学(FNAC)对乳腺癌诊断的敏感性。方法:对138例乳腺癌患者和115例正常对照或其他乳腺病患者分别作血清CA15.3和FNAC检查。结果:血清CA15.3检查乳腺癌的灵敏度为98.26%,特异性为56.52%。FNAC检查乳腺癌的灵敏度为96.52%,特异性为83.33%。结论:血清CA15.3较FNAC更适合作为乳腺癌诊断的筛选指标。Objective To analyze the respective sensitivifies of serum cancer antigen 15.3（CA15.3） diagnosing mammary cancer and of fine needle aspiration cytology （ FNAC - diagnosing mammary carcer. Methods Conduct the serum CA15.3 and FNAC exams respectively on 138 patients with mammary cancer and 115 normal persons or on 138 patients with mammary cancer and patients with other mammary diseases. Results The sensitivity of serum CA15. 3 to mammary cancer is 98.26%. The sensifivity of FNAC to mammary cancer is 96.52% ,specificity is 83.33%. Conclusion Serum CA 15.3 is preferanle to FNAC to be the electing standard diagnosis on mammarv cancer.

关 键 词：血清癌抗原15.3 细针吸取细胞学 乳腺癌 

分 类 号：R737.9[医药卫生—肿瘤]